We are committed to Developing The World's First Cell Therapy to Destroy All Solid Tumours, irrespective of strain or mutation. We are achieving this by  bringing to market a first in class allogeneic innate cell therapy called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT). N-LIfT has the game-changing potential to destroy all solid tumours irrespective of mutation or strain

 

Our first Mission is to show remission in high unmet need solid tumours by 2022,

including Pancreatic Cancer.

 

​